Clinical study on the treatment of medium-late staged esophageal cancer by Chinese-Western medicine and qigong therapy

Author: Cong Jing//Zhang Qiang//Chen Jun//Yang Aiying
Affiliation:
Tumor Hospital, Zibo 255067 China
Conference/Journal: 3rd World Conf Acad Exch Med Qigong
Date published: 1996
Other: Pages: 132 , Special Notes: Some tables are only in Chinese abstracts. , Word Count: 242


A comprehensive therapy of Chinese-Western medicine and qigong has been adopted in our hospital since May, 1991-Dec. 1995. Chinese medicine:compound Tianxian capsule; Western medicine: radiotheraphy and (or) chemotherapy according to patients' pathology type and specific conditions; qigong: Guolin New Qigong: natural movement, express movement relaxation static qigong, sound qigong, one two three steps walking and fast walking. It combines traditional Chinese medicine with modern medicine and integrates biology-society-phychomedicine together. Modern test means, such as image and laboratory test etc. were employed to observe 120 cases suffering from medium-late staged esophageal cancer before and after self-treatment. After statistical management, the result was as follows.
1. There is a very significant difference in the curative effect before and after the comprehensive treatment(p<0.01).
2. There exists a very significant difference in side effect before and after the treatment(p<0.01).
3. The physical state (living quality) after the comprehensive treatment is as follow: increase>stability>decrease. There exists a very significant difference between the two groups (p<0.01).
4. Final results: the survival rate: 5 years: 37.45%; medium survival period: 2-3 years; longer obviously compared with other therapies reported so far. (survival rate: 16-20% for 5 years; medium survival period: 17 months)
The study shows that the comprehensive therapy of Chinese-Western medicine and qigong has the function of improving the curative effect, relieving side effect and improving physical state and prolonging the survival period. Therefore it is the best therapy in the treatment of medium-late staged esophageal cancer so far.

BACK